Search results for: 'pacif value'
- Did you mean
- pacf value
- p7cf value
- Related search terms
- pacif ad coatings global market
- value market research records
- value market research report
- pacif 01 00 00 00
- pacif mining industry market
-
29 Dec 2025  |  North America  |  Market Research
United States Clinical Laboratory Services Growth Opportunities, Forecast 2030
Fueled by Specialty Testing Expansion, Digital Workflow Innovation, and Value-Based Healthcare Demands
The clinical laboratory testing industry will continue to experience growth in testing volumes due to the aging of the US population, patient awareness of the benefits of laboratory testing, test cost reductions, the development of advanced and specialized tests for disease detection and management, the growing awareness of early detection and prev...
$4,950.00 -
19 Feb 2025  |  Global  |  Market Research
Antimicrobial Resistance Diagnostics Market, Global, 2024–2030
The Shift to Whole-genome Sequencing and Multiplex Point-of-care Testing is Driving Transformational Growth Due to Improved Speed, Accuracy, and High Throughput
This Frost & Sullivan report examines the antimicrobial resistance (AMR) diagnostics market in human health. AMR, characterized by bacteria, viruses, and fungi that no longer respond to antimicrobial medications, is one of the top ten global public health threats. When pathogens develop drug resistance, medications become ineffective, leading to in...
$4,950.00
Special Price $4,455.00 save 10 %
-
25 Mar 2026  |  Global  |  Market Research
Global Clinical Diagnostics Industry Growth Opportunities, 2026–2031
Next-Gen AI-Integrated Biomarkers and Smart Automation are Advancing Precision and Early Detection in Molecular and Point-of-Care Diagnostics
The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...
$4,950.00 -
09 Jul 2025  |  Global  |  Market Outlook
Global Clinical Diagnostics Outlook, 2025
Driven by Novel Biomarkers, Digital Services, and Automation, Industry is Accelerating Precision, Efficiency, and Early Disease Detection in Molecular Diagnostics and Point-of-care Testing (POCT)
The global clinical diagnostics market is poised for strong growth as stakeholders shift focus toward high-growth segments such as precision medicine, decentralized diagnostics, software-driven solutions, and product expansion. Companies continue to adopt LIMS and other digital platforms while emerging opportunities in the POCT sector further drive...
$4,950.00
Special Price $4,455.00 save 10 %
-
25 May 2018  |  Europe  |  Market Research
Western European Cardiac Troponin Diagnostics Market, Forecast to 2021
Emerging Biomarkers Disrupt and Spur Growth in the Heart Disease Segment
Cardiac troponins have now become the gold standard for early diagnosis of acute myocardial infarction, making them indispensable for clinical diagnosis of Acute Coronary Syndrome (ACS). Cardiac troponins play a key role in minimizing hospital stays and reducing admission rate which are the biggest contributors to overall healthcare expenditure. Fo...
$3,000.00
Special Price $2,250.00 save 25 %
-
14 Feb 2025  |  Global  |  Market Research
Proteomics Research Tools and Diagnostics Market, Global, 2024-2030
The Proteomics Industry is Experiencing Transformational Growth Due to Advancements in Proteomics Profiling and Biomarker Discovery
In the study, Frost & Sullivan examines the global proteomics research tools and diagnostics market, covering different product types, end users, and technologies. The market is projected to register high growth between 2024 and 2030, reaching significant revenue milestones, largely driven by the research and pharmaceutical segments. The increasing...
$4,950.00
Special Price $4,455.00 save 10 %
-
22 Oct 2025  |  Global  |  Technology Research
Beyond CRISPR: Recent Technology Advances in Rewriting DNA
Emerging Tools Reshaping the Future of Gene Editing
This study highlights advancements such as prime editing, base editing, bridge RNA, SeekRNA, and gene writing platforms, as it examines the emerging field of next-generation gene editing technologies beyond CRISPR/Cas systems. These tools are revolutionary for therapeutic development, precision medicine, and functional genomics because they provide...
$4,950.00 -
16 Dec 2025  |  Europe  |  Market Outlook
Top 10 Growth Opportunities in the European Life Sciences Industry, 2026
Transformational Policies Will Unlock Life Sciences Growth in 2026 Through AI-Enabled Innovation, Digital-Clinical Scale-Up, and Biomanufacturing Resilience
Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...
$2,450.00 -
19 Dec 2025  |  Global  |  Technology Research
Emerging AI-Driven Platforms and Next-Generation Therapeutics: Innovations in Healthcare Analytics, Drug Discovery, Cancer Therapeutics, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...
$950.00 -
29 Aug 2025  |  Global  |  Market Research
Oncology Biomarker Diagnostics, Global, 2024–2030
Regulatory Approvals, Companion Diagnostic Partnerships, and Precision Medicine are Driving Transformational Growth in the Industry, Fueled by Advances in Genomic Profiling and AI Integration
This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...
$4,950.00